Pay in 4 interest-free payments of $7.28 Learn more
Ships within 48 hours · Estimated delivery Aug 12 - Aug 17
Patients typically experience reductions in fasting insulin levels and improved HOMA-IR (Homeostatic Model Assessment for Insulin Resistance) scores, indicating enhanced insulin sensitivity
Zhao et al., 2021a)
National Center for Advancing Translational Sciences
Frequency not known: facial oedema
Retatrutide dosing protocol Retatrutide uses a different titration approach, reflecting its greater potency and triple-receptor activity: Weeks 1-4: 1 mg once weekly (starting dose) Weeks 5-8: 2 mg once weekly Weeks 9-12: 4 mg once weekly Weeks 13-16: 8 mg once weekly Week 17 onward: 8-12 mg once weekly (maintenance dose) Some trial protocols use a slightly modified schedule, escalating every four weeks with dose increases of approximately double at each step
Diabetes Care 42 , 14961503 (2019)
